论文已发表
注册即可获取德孚的最新动态
IF 收录期刊
全身炎症指标和新发代谢不健康表型的风险
Authors Zhao L , Cui M, Yang S, Zhou H, Li M
Received 19 June 2024
Accepted for publication 20 September 2024
Published 30 September 2024 Volume 2024:17 Pages 6905—6916
DOI https://doi.org/10.2147/JIR.S474201
Checked for plagiarism Yes
Review by Single anonymous peer review
Peer reviewer comments 2
Editor who approved publication: Professor Ning Quan
Linlin Zhao,1,2 Man Cui,3 Saiqi Yang,1,2 Hui Zhou,1,2 Meng Li4
1Health Management Medicine Center, The Third Xiangya Hospital, Central South University, Changsha, Hunan, People’s Republic of China; 2Health Management Research Center, Central South University, Changsha, Hunan, People’s Republic of China; 3Department of Medical Administration, The Second Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Jinan, Shandong, People’s Republic of China; 4Department of Endocrinology, The Second Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Jinan, Shandong, People’s Republic of China
Correspondence: Meng Li, Email limeng5136@126.com
Objective: This retrospective cohort study was designed to evaluate the association between eight systemic inflammation indicators at baseline and the metabolically unhealthy (MU) phenotype after two years of follow-up.
Methods: Participants were defined as metabolically healthy (MH) if they met 0– 2 of the criteria and metabolically unhealthy (MU) if they met ≥ 3 of the criteria. A many of 4175 subjects aged 20– 80 years with a metabolically healthy (MH) phenotype at baseline were enrolled in the study. We compared the clinical characteristics between women and men enrolled at baseline according to the metabolic phenotype at follow-up. The associations between baseline inflammation indicators and MU status at follow-up were evaluated using logistic regression analysis.
Results: 922 (22.08%) developed new-onset MU symptoms during follow-up. Logistic regression analysis found that most inflammation indicators were significantly associated with MU phenotype at follow-up, aside from the LMR and SII. After adjusting for potential confounders, only the correlations between CRP level, neutrophil count, and MU phenotype reached significance. In comparison to the control group with a CRP of < 0.50 mg/L, the odds ratios (ORs) and 95% confidence intervals (CIs) were 1.61 (1.25– 2.09), 1.49 (1.15– 1.94), and 1.68 (1.30– 2.18) for individuals with CRP levels of 0.50– 0.90 mg/L, 0.91– 1.72 mg/L, and above 1.72 mg/L, respectively. In the population with a neutrophil count < 5.00 × 109 cells/L, the neutrophil count correlated positively and significantly with the MU phenotype. In comparison to the control group with a neutrophil count of < 2.75 × 109 cells/L, the ORs and 95% CIs were 1.65 (1.30– 2.09) in the population with neutrophil count > 4.17 × 109 cells/L.
Conclusion: CRP and neutrophil counts positively correlated with the risk of MU phenotype in Chinese subjects. These composite inflammatory markers (NLR, PLR, LMR, and SII) provide limited advantages for predicting MU risks compared to CRP.
Keywords: systemic inflammation indicators, metabolically unhealthy phenotype, C-reactive protein, CRP